Skip to main content
Log in

Temporal trend and factors associated with post-endoscopic retrograde cholangiopancreatography pancreatitis in children in the USA: a nationwide, retrospective cohort study

  • RESEARCH
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Pancreatitis is the most common adverse event following endoscopic retrograde cholangiopancreatography (ERCP). Meanwhile, the national temporal trend of post-ERCP pancreatitis (PEP) in children remains to be reported. The purpose of this study is to investigate the temporal trend and factors associated with PEP in children. We conducted a nationwide study using data from the National Inpatient Sample database during 2008–2017 and included all patients aged ≤ 18 years who underwent ERCP. The primary outcomes were temporal trends and factors associated with PEP. The secondary outcomes were in-hospital mortality, total charges (TC), and total length of stay (LOS). A total of 45,268 hospitalized pediatric patients who underwent ERCP were analyzed; of whom, 2043 (4.5%) were diagnosed with PEP. The prevalence of PEP decreased from 5.0% in 2008 to 4.6% in 2017 (P = 0.0002). In multivariable logistic analysis, adjusted risk factors of PEP were hospitals located in the West (aOR 2.09, 95% CI 1.36–3.20; P < .0001), bile duct stent insertion (aOR 1.49, 95% CI, 1.08–2.05; P = 0.0040), and end-stage renal disease (aOR 8.05, 95% CI 1.66–39.16; P = 0.0098). Adjusted protective factors of PEP were increasing age (aOR 0.95, 95% CI 0.92–0.98; P = 0.0014) and hospitals located in the South (aOR 0.53, 95% CI 0.30–0.94; P < .0001). In-hospital mortality, TC, and LOS were higher in patients with PEP than those without PEP.

Conclusion: This study shows a decreasing national trend over time and identifies multiple protective and risk factors for pediatric PEP. Endoscopists can use the insights from this study to evaluate relevant factors before performing ERCP in children to prevent PEP and reduce the medical-care burden.

What is Known:

• Although ERCP has become indispensable procedure in children as they are in adults, education and training programs for ERCP in children are underdeveloped in many countries.

PEP is the most common and most serious adverse event following ERCP. Research on PEP in adults showed rising hospital admission and mortality rates associated with PEP in the USA.

What is New:

• The national temporal trend of PEP among pediatric patients in the USA was decreasing from 2008 to 2017.

• Older age was a protective factor for PEP in children, while end-stage renal disease and stent insertion into the bile duct were risk factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

The data used in the study is publicly available.

Abbreviations

aOR:

Adjusted odds ratio

CI:

Confidence interval

ERCP:

Endoscopic retrograde cholangiopancreatography

HCUP:

Healthcare Cost and Utilization Project

ICD-9-CM:

International Classification of Diseases, 9th revisions-Clinical Modification

ICD-10-CM:

International Classification of Diseases, 10th revisions-Clinical Modification

IQR:

Interquartile range

LOS:

Length of stay

NIS:

National Inpatient Sample

NSAIDs:

Non-steroidal anti-inflammatory drugs

OR:

Odds ratio

PEP:

Post-ERCP pancreatitis

TC:

Total charges

References

  1. Adler DG, Baron TH, Davila RE, Egan J, Hirota WK, Leighton JA, Qureshi W, Rajan E, Zuckerman MJ, Fanelli R, Wheeler-Harbaugh J, Faigel DO, Standards of Practice Committee of American Society for Gastrointestinal E (2005) ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc 62(1):1–8. https://doi.org/10.1016/j.gie.2005.04.015

    Article  Google Scholar 

  2. Cotton PB (2018) Fifty years of ERCP: a personal review. Gastrointest Endosc 88(2):393–396. https://doi.org/10.1016/j.gie.2018.04.013

    Article  PubMed  Google Scholar 

  3. Waye JD (1976) Endoscopic retrograde cholangiopancreatography in the infant. Am J Gastroenterol 65(5):461–463

    CAS  PubMed  Google Scholar 

  4. Mercier C, Pioche M, Albuisson E, Ponchon T, Gonzalez JM, Barthet M, Boytchev I, Vanbiervliet G, Fortier Beaulieu C, Prat F, Belle A, Branche J, Grandval P, Valats JC, Rudler F, Wallenhorst T, Koch S, Comte A, Williet N, Musquer N, Coron E, Derosiere A, Le Mouel JP, Schaefer M, Chabot C, Scheers I, Deprez PH, Chevaux JB (2021) Safety of endoscopic retrograde cholangiopancreatography in the pediatric population: a multicenter study. Endoscopy 53(6):586–594. https://doi.org/10.1055/a-1209-0155

    Article  PubMed  Google Scholar 

  5. Goetz M, Andersen P, Bergman J, Frei N, Schmidt A, Kahler G, Martus P, Dechene A (2020) ERCP in babies: low risk of post-ERCP pancreatitis - results from a multicentre survey. United European Gastroenterol J 8(1):77–80. https://doi.org/10.1177/2050640619874187

    Article  PubMed  Google Scholar 

  6. Troendle DM, Abraham O, Huang R, Barth BA (2015) Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population. Gastrointest Endosc 81(6):1408–1416. https://doi.org/10.1016/j.gie.2014.11.022

    Article  PubMed  Google Scholar 

  7. Giefer MJ, Kozarek RA (2015) Technical outcomes and complications of pediatric ERCP. Surg Endosc 29(12):3543–3550. https://doi.org/10.1007/s00464-015-4105-1

    Article  PubMed  Google Scholar 

  8. Iqbal CW, Baron TH, Moir CR, Ishitani MB (2009) Post-ERCP pancreatitis in pediatric patients. J Pediatr Gastroenterol Nutr 49(4):430–434. https://doi.org/10.1097/01.mpg.0000361657.54810.19

    Article  PubMed  Google Scholar 

  9. Cheng CL, Fogel EL, Sherman S, McHenry L, Watkins JL, Croffie JM, Gupta SK, Fitzgerald JF, Lazzell-Pannell L, Schmidt S, Lehman GA (2005) Diagnostic and therapeutic endoscopic retrograde cholangiopancreatography in children: a large series report. J Pediatr Gastroenterol Nutr 41(4):445–453. https://doi.org/10.1097/01.mpg.0000177311.81071.13

    Article  PubMed  Google Scholar 

  10. Felux J, Sturm E, Busch A, Zerabruck E, Graepler F, Stuker D, Manger A, Kirschner HJ, Blumenstock G, Malek NP, Goetz M (2017) ERCP in infants, children and adolescents is feasible and safe: results from a tertiary care center. United European Gastroenterol J 5(7):1024–1029. https://doi.org/10.1177/2050640616687868

    Article  PubMed  PubMed Central  Google Scholar 

  11. Deng Z, Zeng J, Lv C, Jiang L, Ji J, Li X, Hao L, Gong B (2021) Prevalence and factors associated with post-endoscopic retrograde cholangiopancreatography pancreatitis in children. Dig Dis Sci 66(1):224–230. https://doi.org/10.1007/s10620-020-06179-5

    Article  CAS  PubMed  Google Scholar 

  12. Barakat MT, Cholankeril G, Gugig R, Berquist WE (2021) Nationwide evolution of pediatric endoscopic retrograde cholangiopancreatography indications, utilization, and readmissions over time. J Pediatr 232:159–165 e151. https://doi.org/10.1016/j.jpeds.2020.11.019

  13. Agency for healthcare research and quality. Nationwide HCUP databases. Available at: https://www.hcup-us.ahrq.gov/databases.jsp. Accessed 21 Sep 2022

  14. Agency for healthcare research and quality. Overview of the National (Nationwide) Inpatient Sample (NIS). Available at: https://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed 21 Sep 2022

  15. Agency for healthcare research and quality. HCUP quality control procedures. Available at: https://www.hcup-us.ahrq.gov/db/quality.pdf. Accessed 21 Sep 2022

  16. Inamdar S, Slattery E, Bhalla R, Sejpal DV, Trindade AJ (2016) Comparison of adverse events for endoscopic vs percutaneous biliary drainage in the treatment of malignant biliary tract obstruction in an inpatient national cohort. JAMA Oncol 2(1):112–117. https://doi.org/10.1001/jamaoncol.2015.3670

    Article  PubMed  Google Scholar 

  17. Wandling MW, Hungness ES, Pavey ES, Stulberg JJ, Schwab B, Yang AD, Shapiro MB, Bilimoria KY, Ko CY, Nathens AB (2016) Nationwide assessment of trends in choledocholithiasis management in the United States From 1998 to 2013. JAMA Surg 151(12):1125–1130. https://doi.org/10.1001/jamasurg.2016.2059

    Article  PubMed  Google Scholar 

  18. Suarez AL, Xu H, Cotton PB, Elmunzer BJ, Adams D, Morgan KA, Sheafor D, Cote GA (2018) Trends in the timing of inpatient ERCP relative to cholecystectomy: a nationwide database studied longitudinally. Gastrointest Endosc 88(3):502–510 e504. https://doi.org/10.1016/j.gie.2018.04.2354

  19. Yadav D, O’Connell M, Papachristou GI (2012) Natural history following the first attack of acute pancreatitis. Am J Gastroenterol 107(7):1096–1103. https://doi.org/10.1038/ajg.2012.126

    Article  PubMed  Google Scholar 

  20. Inamdar S, Berzin TM, Sejpal DV, Pleskow DK, Chuttani R, Sawhney MS, Trindade AJ (2016) Pregnancy is a risk factor for pancreatitis after endoscopic retrograde cholangiopancreatography in a national cohort study. Clin Gastroenterol Hepatol 14(1):107–114. https://doi.org/10.1016/j.cgh.2015.04.175

    Article  PubMed  Google Scholar 

  21. Mutneja HR, Vohra I, Go A, Bhurwal A, Katiyar V, Palomera Tejeda E, Thapa Chhetri K, Baig MA, Arora S, Attar B (2021) Temporal trends and mortality of post-ERCP pancreatitis in the United States: a nationwide analysis. Endoscopy 53(4):357–366. https://doi.org/10.1055/a-1220-2242

    Article  PubMed  Google Scholar 

  22. Agency for healthcare research and quality. NIS description of data elements. Available at: https://www.hcup-us.ahrq.gov/db/nation/nis/nisdde.jsp. Accessed 21 Sep 2022

  23. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49(12):1373–1379. https://doi.org/10.1016/s0895-4356(96)00236-3

    Article  CAS  PubMed  Google Scholar 

  24. Wang F, Shin H-C SAS® model selection macros for complex survey data using PROC SURVEYLOGISTIC/SURVEYREG. https://www.mwsug.org/proceedings/2011/stats/MWSUG-2011-SA02.pdf

  25. Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, Overby CS, Aas J, Ryan ME, Bochna GS, Shaw MJ, Snady HW, Erickson RV, Moore JP, Roel JP (2001) Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 54(4):425–434. https://doi.org/10.1067/mge.2001.117550

    Article  CAS  PubMed  Google Scholar 

  26. Freeman ML, Guda NM (2004) Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc 59(7):845–864. https://doi.org/10.1016/s0016-5107(04)00353-0

    Article  PubMed  Google Scholar 

  27. George S, Kulkarni AA, Stevens G, Forsmark CE, Draganov P (2004) Role of osmolality of contrast media in the development of post-ERCP pancreatitis: a metanalysis. Dig Dis Sci 49(3):503–508. https://doi.org/10.1023/b:ddas.0000020511.98230.20

    Article  PubMed  Google Scholar 

  28. Limketkai BN, Chandrasekhara V, Kalloo AN, Okolo PI 3rd (2013) Comparison of performance and safety of endoscopic retrograde cholangiopancreatography across pediatric age groups. Dig Dis Sci 58(9):2653–2660. https://doi.org/10.1007/s10620-013-2691-0

    Article  PubMed  Google Scholar 

  29. Committee ASoP, Chandrasekhara V, Khashab MA, Muthusamy VR, Acosta RD, Agrawal D, Bruining DH, Eloubeidi MA, Fanelli RD, Faulx AL, Gurudu SR, Kothari S, Lightdale JR, Qumseya BJ, Shaukat A, Wang A, Wani SB, Yang J, DeWitt JM, (2017) Adverse events associated with ERCP. Gastrointest Endosc 85(1):32–47. https://doi.org/10.1016/j.gie.2016.06.051

    Article  Google Scholar 

  30. Wilcox CM, Phadnis M, Varadarajulu S (2010) Biliary stent placement is associated with post-ERCP pancreatitis. Gastrointest Endosc 72(3):546–550. https://doi.org/10.1016/j.gie.2010.05.001

    Article  PubMed  Google Scholar 

  31. Shin SH, So H, Cho S, Kim N, Baik GH, Lee SK, Park DH (2020) The number of wire placement in the pancreatic duct and metal biliary stent as risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis. J Gastroenterol Hepatol 35(7):1201–1207. https://doi.org/10.1111/jgh.14957

    Article  CAS  PubMed  Google Scholar 

  32. Cote GA, Kumar N, Ansstas M, Edmundowicz SA, Jonnalagadda S, Mullady DK, Azar RR (2010) Risk of post-ERCP pancreatitis with placement of self-expandable metallic stents. Gastrointest Endosc 72(4):748–754. https://doi.org/10.1016/j.gie.2010.05.023

    Article  PubMed  Google Scholar 

  33. Troendle DM, Gurram B, Huang R, Barth BA (2020) IV ibuprofen for prevention of post-ERCP pancreatitis in children: a randomized placebo-controlled feasibility study. J Pediatr Gastroenterol Nutr 70(1):121–126. https://doi.org/10.1097/MPG.0000000000002524

    Article  PubMed  Google Scholar 

Download references

Funding

The following author received research support for this study from the Three-Year Action Plan for Strengthening Public Health System in Shanghai (2020–2022) Subject Chief Scientist (grant GWV-10.2-XD05), Natural Science Foundation of Shanghai (grant 19ZR1469800): C. Wu; and the National Natural Science Foundation of China (grant 81803335): J. Xu.

Author information

Authors and Affiliations

Authors

Contributions

Ronghui Zhu and Shengyong Wu designed the research, had full access to the data, conducted all analyses, and wrote the draft of this paper. Jinfang Xu, Rui Wang, Yi Cheng, Yetao Xu, and Chenxin Chen revised the article critically. All the authors contributed to the manuscript writing, read, and approved the final manuscript. Cheng Wu was the guarantor.

Corresponding author

Correspondence to Cheng Wu.

Ethics declarations

Ethical approval

Because the NIS databases were deidentified for public availability, our study was exempted from the requirement of institutional review board approval.

Conflict of interest

The authors declare no competing interests.

Additional information

Communicated by Gregorio Milani.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 19 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhu, R., Wu, S., Xu, J. et al. Temporal trend and factors associated with post-endoscopic retrograde cholangiopancreatography pancreatitis in children in the USA: a nationwide, retrospective cohort study. Eur J Pediatr 182, 2273–2282 (2023). https://doi.org/10.1007/s00431-023-04902-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-023-04902-8

Keywords

Navigation